Resilience Care & InterSystems Partner to Streamline Oncology Care Pathways

Key Takeaways

• Resilience Care monitors oncology patients via remote platform
• InterSystems IRIS for Health provides integration layer
• Automatic data sync eliminates duplicate entries, saves staff time
• Solution already deployed in 170 facilities, serving 25k patients
• Partnership aims to expand to gastroenterology and psychiatry

Summary

InterSystems and Resilience Care have formed a technology partnership to integrate Resilience Care’s remote‑monitoring platform with InterSystems IRIS for Health, streamlining oncology care pathways. The integration layer connects hospital information systems, automates data exchange for chemotherapy, lab, and imaging appointments, and eliminates duplicate entries. Production began in October 2025, with deployments across more than 170 facilities serving over 25,000 patients. The collaboration also targets expansion into gastroenterology and psychiatry, aiming to improve clinical efficiency and patient experience.

Pulse Analysis

The alliance between InterSystems and Resilience Care arrives at a moment when hospitals are accelerating digital transformation to meet the growing demand for remote patient monitoring. Oncology, with its intensive treatment schedules and side‑effect management, has become a prime use case for continuous data capture. Resilience Care’s platform collects electronic patient‑reported outcomes (ePROs) and vital signs through a mobile app, feeding real‑time information to clinicians. By embedding this capability within InterSystems’ IRIS for Health, the partnership leverages a proven data‑management engine that already powers health systems in more than 80 countries, ensuring the solution can scale quickly across diverse IT environments.

From a technical standpoint, IRIS for Health acts as a universal interoperability hub, translating between HL7 v2, FHIR R4, IHE PAM France and HPRIM XML formats. This eliminates the need for custom point‑to‑point interfaces, reducing integration costs and deployment time. Automatic synchronization of chemotherapy schedules, lab results and imaging studies removes duplicate data entry, freeing nurses and physicians to focus on clinical decision‑making rather than administrative tasks. The standardized data layer also supports analytics and research, allowing institutions to aggregate real‑world evidence from thousands of oncology patients while maintaining strict security and compliance standards.

The practical impact is evident: more than 170 hospitals and clinics have already adopted the solution, covering over 25,000 patients and extending beyond oncology into gastroenterology and psychiatry. By streamlining care pathways, the partnership promises shorter hospital stays, earlier detection of adverse events, and higher patient satisfaction. For vendors, the model demonstrates how a robust integration platform can accelerate market penetration of niche digital therapeutics. As payers increasingly tie reimbursement to outcomes, solutions that combine seamless data flow with proactive monitoring are likely to become essential components of value‑based care strategies worldwide.